Several inflammatory, proteolytic, angiogenic and bone-associated factors play a role in the development of autoimmune, accelerated atherosclerosis in rheumatic diseases. Some of these may serve as biomarkers of vascular pathology and may be useful in the follow-up of vascular damage and outcome. Multi-biomarker profiles rather than a single markers would likely be optimal in this respect.
Keywords: Angiogenesis; Autoimmune atherosclerosis; Autoimmunity; Biomarkers; Cardiovascular disease.
Copyright © 2018 Elsevier Inc. All rights reserved.